Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Potent Induction of Phase 2 Enzymes in Human Prostate Cells by Sulforaphane

James D. Brooks, Vincent G. Paton and Genevieve Vidanes
James D. Brooks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent G. Paton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Genevieve Vidanes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published September 2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Transcriptional response of phase 2 enzymes to sulforaphane in various prostate cancer cell lines. The cell lines LNCaP, MDA PCa 2A, MDA PCa 2B, PC3, and TSU-Pr1 were treated for 8 h with 10 μm sulforaphane or with the DMSO control. Northern blot analyses were performed using (A) NQO-1, (B) GSTA1, (C) microsomal GST, and (D) GAPDH cDNA probes.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Northern blot analysis of the transcriptional response to sulforaphane. LNCaP cells were incubated for 1 to 72 h with 10 μm sulforaphane or the DMSO control before the RNA was harvested. The membrane was probed with labeled (A) NQO-1 and (B) GAPDH cDNAs.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Differential effects of sulforaphane on γ-GCS subunits. Northern blot analyses of (A) sulforaphane-induced γ-GCS light chain expression over time and (B) unchanged γ-GCS heavy chain expression treated with 9 h of 10 μm sulforaphane treatment in LNCaP cells.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    QR response to sulforaphane is abolished in a reduced environment. LNCaP cells were pretreated for 2 h with 10 μm NAC followed by 8 μm sulforaphane or DMSO control before assaying QR activity. Bars, SD of triplicate data points.

Tables

  • Figures
  • Table 1

    Dose-dependent induction of quinone reductase activity in response to sulforaphane

    μm sulforaphane
    151085310.50.1
    LNCaP1.982.291.932.111.391.281.111.00
    MDA Pca 2a1.671.602.101.991.891.310.941.04
    MDA Pca 2b1.522.472.101.921.901.701.251.04
    TSU-Pr11.861.281.391.141.211.010.950.92
    Normal strain1.811.861.801.952.462.081.571.35
  • Table 2

    Dose-dependent induction of quinone reductase activity in response to broccoli sprout extract

    Percentage of broccoli sprout extract
    1.2500.6250.3130.1560.0780.0390.020
    LNCaP1.1381.9742.1341.4621.1761.0440.957
  • Table 3

    Dose-dependent induction of cellular glutathione by sulforaphane

    μm sulforaphane
    151085310.50.1
    LNCaP1.1031.1791.1521.1721.1221.0511.0341.009
PreviousNext
Back to top
September 2001
Volume 10, Issue 9
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Potent Induction of Phase 2 Enzymes in Human Prostate Cells by Sulforaphane
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Potent Induction of Phase 2 Enzymes in Human Prostate Cells by Sulforaphane
James D. Brooks, Vincent G. Paton and Genevieve Vidanes
Cancer Epidemiol Biomarkers Prev September 1 2001 (10) (9) 949-954;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Potent Induction of Phase 2 Enzymes in Human Prostate Cells by Sulforaphane
James D. Brooks, Vincent G. Paton and Genevieve Vidanes
Cancer Epidemiol Biomarkers Prev September 1 2001 (10) (9) 949-954;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Early-Life Risk Factors for Breast Cancer
  • Sugary Drink Consumption and Colorectal Cancer Risk
  • HPV Testing in Self-samples and Urine
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement